New ETF Book by Larry Connors - Click here to read more
CytRx Corp. (NASDAQ: CYTR | Quote | Chart | News | PowerRating) a biopharmaceutical research and development company, engages in developing human therapeutic products primarily based upon small molecule molecular chaperone co-induction technology. The company has completed a Phase IIa clinical trial of its small molecule product candidate, arimoclomol, for the treatment of amyotrophic lateral sclerosis or Lou Gehrig's disease. It intends to start a Phase IIb clinical trial as soon as the FDA provides clearance; and to commence a Phase II clinical trial of arimoclomol for the treatment of stroke damage repair and a Phase II clinical trial of iroxanadine for the treatment of diabetic foot ulcers. In addition, the company owns 49% of RXi Pharmaceuticals, which develops therapeutic products based upon ribonucleic acid interference technologies for the treatment of human diseases, including neurodegenerative diseases, cancer, type 2 diabetes, and obesity. The company was founded in 1985 and is headquartered in Los Angeles, California. With 90.77 million shares outstanding and 6.58 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of CYTR. According to quarterly data provided by the SEC, there were still 23,456 shares of CYTR that were failing-to-deliver as of September 28, 2007.
Hydrogenics Corp. (NASDAQ: HYGS | Quote | Chart | News | PowerRating) develops and provides hydrogen and fuel cell products and services worldwide. The company's OnSite Generation group sells hydrogen generation products to industrial, transportation, and renewable energy customers. Its Power Systems group sells fuel cell products to original equipment manufacturers (OEMs), systems integrators, and end users for stationary applications, such as backup power and light mobility applications, including forklift trucks. Hydrogenics Corporation's Test Systems group provides testing services to third parties to validate their fuel cell development efforts. Its products and services include the HySTAT Generator for producing continuous or batch supplies of hydrogen for industrial processing applications; HySTAT Hydrogen Stations that offer onsite supply of hydrogen for various hydrogen applications, including vehicle refueling, distributed power, and industrial processes; HyPM Fuel Cell Power Modules that produce direct current (DC) power in standard outputs; HyPX Fuel Cell Power Pack comprising HyPM power module integrated with hydrogen storage tanks and ultracapacitors that provide higher power in short bursts; and Integrated Fuel Cell Systems for portable and stationary applications, including portable and auxiliary power units for military applications and DC backup power system for cellular tower sites. The company also offers FCATS Test Stations that perform testing and diagnostic functions; and testing and diagnostic services. The company was founded in 1988 as Traduction Militech Translation, Inc. It changed its name to Hydrogenics Corporation Incorporated in 1990 and to Hydrogenics Corporation in 2000. The company is headquartered in Mississauga, Canada. With 91.77 million shares outstanding and 1.36 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of HYGS. According to quarterly data provided by the SEC, there were still 136,418 shares of HYGS that were failing-to-deliver as of September 28, 2007.
Jamba Inc. (NASDAQ: JMBA | Quote | Chart | News | PowerRating) through its subsidiary, Jamba Juice Company, owns and franchises Jamba Juice stores. The company operates as a retailer of blended-to-order fruit smoothies, squeezed-to-order juices, blended beverages, and snacks in the United States. As of January 1, 2008, it operated 707 stores comprising 501 company-owned stores and 206 franchisee-owned stores. The company was founded in 1990 and is headquartered in Emeryville, California. With 52.64 million shares outstanding and 7 million shares declared short as of May 2008, there is no longer a failure to deliver in shares of JMBA. According to quarterly data provided by the SEC, there were still 10,110 shares of JMBA that were failing-to-deliver as of September 27, 2007.
MEDecision Inc. (NASDAQ: MEDE | Quote | Chart | News | PowerRating) together with its subsidiaries, provides collaborative health care management solutions, including integrated software, services, and clinical content to health care payers in the United States. Its collaborative health care management solutions include Alineo, a platform addressing case management, disease management, and utilization management within a payer organization; and Nexalign, a collaborative health information exchange service. The Alineo solution provides intuitive predictive modeling tools to identify patients who can immediately benefit from case and disease management programs; delivers turnkey clinical knowledge and pathways based on embedded clinical content; and allows payers to administer and evaluate member and population-wide health care programs, including approvals, referrals, and extensions. Its Nexalign solution provides a solution for health care payers, patients, physicians, and other health care providers to securely access and exchange health information for clinical decisions. Nexalign is designed around Clinical Summaries, which are payer-based electronic health records that have been clinically validated. In addition, the company develops MEDeWeaver, a technology that gathers patient data stored in several different databases, and analyzes this data for inconsistencies and combines them into one report. MEDecision licenses its solutions to managed care organizations and health insurance companies primarily through its direct sales force. The company also offers professional services, including implementation, consulting, and training. MEDecision was incorporated in 1988 and is headquartered in Wayne, Pennsylvania. With 16.29 million shares outstanding and 8,300 shares declared short as of May 2008, there is no longer a failure to deliver in shares of MEDE. According to quarterly data provided by the SEC, there were still 48,678 shares of MEDE that were failing-to-deliver as of September 28, 2007.
Empire Resorts Inc. (NASDAQ: NYNY | Quote | Chart | News | PowerRating) through its subsidiaries, operates in the hospitality and gaming industries in New York. It owns and operates Monticello Gaming and Raceway, a harness horseracing facility that conducts pari-mutuel wagering through the running of live harness horse races, the import simulcasting of harness and thoroughbred horse races, and the export simulcasting of its races to offsite pari-mutuel wagering facilities. As of December 31, 2007, the company operated approximately 1,500 video gaming machines at the grandstand of Monticello Gaming and Raceway. Empire Resorts, Inc. was founded in 1993 and is based in Henderson, Nevada. With 30.52 million shares outstanding and 738,400 shares declared short as of May 2008, there is no longer a failure to deliver in shares of NYNY. According to quarterly data provided by the SEC, there were still 42,064 shares of NYNY that were failing-to-deliver as of September 10, 2007.
Ecosphere Technologies Inc. (OTCBB: ESPH | Quote | Chart | News | PowerRating) a water-centric technology company, together with its subsidiaries, designs, builds, develops, and commercializes clean technology products, services, and solutions in the United States. Its mobile water filtration equipment treats complex industrial and energy related wastewaters; robotic water-jetting technology removes paint from large commercial and military aircraft and automobiles; and Ecos Lifelink, a micro utility produces the electrical current to run its water filtration system. The company's products provide clean water for various domestic and international markets, including natural disasters and homeland security; military, commercial, and industrial applications; and remote areas in third world countries off the power grid. The company develops Ecosphere Ozonix process, an oxidation process that is developed to treat and recycle industrial wastewater in various markets, including oil and gas industry; marine industry to treat ballast wastewater; purification of industrial process plant effluents; mining industry; pulp and paper industry; coal energy industry; and municipal wastewater. It also develops Ecos Com Cube, which is designed to link satellite telecommunications systems to the Ecos Com Cube and provide cellular telephone, VOIP services, and Internet connection services to residents of remote, off-grid areas of third world countries using renewable energy generated by the solar panels and wind turbine. The company has a non-binding agreement with WaterEye Corporation that develops an Internet-based system of remote monitoring of the condition of water used by municipal water facilities, refineries, power plants, and manufacturing plants. It was formerly known as UltraStrip Systems, Inc. Ecosphere Technologies, Inc. was founded in 1998 and is headquartered in Stuart, Florida. With 66.38 million shares outstanding and 4,900 shares declared short as of May 2008, there is no longer a failure to deliver in shares of ESPH. According to quarterly data provided by the SEC, there were still 56,666 shares of ESPH that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
